Definitive chromosomal answers as early as 11 weeks —
when time matters most
Chorionic villus sampling (CVS) is an invasive prenatal diagnostic procedure in which a small sample of placental tissue — called the chorionic villi — is collected under ultrasound guidance and sent to a genetics laboratory for chromosomal analysis.
Because the chorionic villi and the baby share the same genetic material, this tiny biopsy reveals the baby's complete chromosomal blueprint. Every test available through amniocentesis — karyotype, chromosomal microarray, FISH, single-gene testing — can be obtained through CVS, but weeks earlier, in the first trimester.
At Mayflower Fetal Medicine Centre, CVS is performed by Dr. Kunda Shahane — Central India's first fetal medicine specialist — under continuous real-time guidance on the GE Voluson Signature Expert. High-definition visualisation of the placenta and needle throughout the procedure maximises both safety and accuracy.
Both CVS and amniocentesis provide definitive chromosomal diagnosis — the choice depends primarily on timing and your individual clinical situation. Dr. Kunda Shahane will counsel you carefully on which is most appropriate for you.
| CVSChorionic Villus Sampling | AmniocentesisMid-Trimester Procedure | |
|---|---|---|
| Timing | 11–14 weeksEarlier | 15–20 weeks |
| Sample Collected | Placental tissue (chorionic villi) | Amniotic fluid |
| Available Tests | Karyotype · Microarray · FISH · Single-gene | Karyotype · Microarray · FISH · Single-gene |
| FISH Result Time | 1 week | 1 week |
| Full Karyotype | 3 weeks | 3 weeks |
| Miscarriage Risk | ~0.5–1% | ~0.1–0.3%Lower |
| Procedure Route | Transabdominal or Transcervical | Transabdominal only |
| Best For | When first-trimester answers are essential | When slightly lower procedural risk is the priority |
| Limitation | Not suitable if placenta position is technically difficult; slightly higher risk | Cannot be performed before 15 weeks |
Dr. Kunda Shahane will review your scan, NT result, and clinical history before recommending CVS or amniocentesis.
CVS is offered when definitive chromosomal diagnosis is needed in the first trimester — often after a screening result that indicates increased risk, or when the family's situation requires the earliest possible answer to plan and prepare.
An increased nuchal translucency (NT ≥3.5 mm) or a high-risk combined first trimester screening result raises the possibility of chromosomal conditions and may warrant definitive testing.
NIPT is a screening test, not a diagnosis. A positive or high-risk NIPT result must be confirmed by an invasive test — CVS or amniocentesis — before any clinical decisions are made.
Families who have had a previous child or pregnancy with a chromosomal condition, or who carry a known heritable chromosomal or single-gene disorder, may benefit from early definitive testing.
Women aged 35 and above have a naturally higher baseline risk for chromosomal conditions. When combined with other risk factors, first-trimester testing via CVS may be recommended.
If an anomaly — increased nuchal fold, absent nasal bone, or other structural finding — is detected at the 11–14 week scan, chromosomal analysis is often recommended alongside further surveillance.
Parents carrying a balanced translocation, inversion, or other chromosomal rearrangement have a significant risk of passing an unbalanced form to the baby. Early diagnosis allows full time to assess and plan.
CVS can be performed by two routes, depending on the position of the placenta and Dr. Kunda's assessment. Both approaches yield the same quality of tissue sample and the same diagnostic information.
A thin needle is guided through the abdominal wall and uterine wall into the placenta — under continuous real-time ultrasound guidance. The GE Voluson Signature Expert provides high-definition imaging throughout, keeping the needle tip visible at all times.
This is the preferred route for most cases, particularly when the placenta is anterior (front wall), fundal (top), or lateral. The needle is very thin and the sampling takes 5–10 minutes. Local anaesthesia is generally not required.
A thin flexible catheter is passed through the cervical opening (cervix) and guided to the placenta under ultrasound guidance. A small amount of chorionic villi is drawn up gently through the catheter.
This approach is used when the placenta is in a position that makes transabdominal access technically difficult — for example, a posterior placenta lying flat against the back wall of the uterus.
The optimal route is determined by Dr. Kunda Shahane after reviewing your ultrasound findings. You will be advised on the planned approach at your pre-procedure consultation.
The chorionic villi collected during CVS carry the same chromosomal and genetic information as your baby. This tissue sample can be used for several laboratory tests, depending on your clinical indication and what Dr. Kunda recommends.
CVS is not simply a sampling procedure. It begins with a thorough pre-procedure assessment by Dr. Kunda — using the GE Voluson Signature Expert — to plan the safest approach and confirm that the procedure is appropriate at this moment in your pregnancy.
Precise dating by crown-rump length (CRL) measurement to confirm the pregnancy is within the 11–14 week window. CVS before 11 weeks carries a higher risk of fetal complications and is not performed.
Detailed assessment of whether the placenta is anterior, posterior, fundal, or lateral — and which approach (transabdominal or transcervical) provides the safest and most direct access.
Confirming an active fetal heartbeat before proceeding. CVS is not performed if there is any concern about fetal viability at the time of the procedure.
Evaluating uterine position (anteverted, retroverted), the presence of fibroids near the planned needle path, and overall accessibility to ensure safe, unobstructed entry.
Confirming the clinical indication, reviewing NT measurements and screening results, explaining the procedure, risks, and result timeline — and ensuring fully informed consent before proceeding.
Rh-negative women need Anti-D immunoglobulin after CVS to prevent Rh sensitisation. Dr. Kunda confirms blood group status and ensures Anti-D prophylaxis is arranged before the procedure.
Dr. Kunda Shahane and her team will guide you through every step. The sampling itself takes 5–10 minutes, but your total clinic time will be longer — to allow for thorough assessment, counselling, the procedure, and post-procedure monitoring.
Dr. Kunda performs a detailed scan using the GE Voluson Signature Expert to confirm gestational age, fetal viability, placental position, and uterine anatomy. This determines the safest needle route, entry point, and which of the two approaches will be used.
Dr. Kunda explains the procedure and the specific risks in your case, reviews what tests will be performed on the sample, discusses the result timeline, and ensures all your questions are answered. Written informed consent is obtained before proceeding.
For transabdominal CVS, the abdomen is cleaned with antiseptic solution. For transcervical CVS, the vaginal area is prepared. You remain awake and positioned comfortably throughout. Local anaesthesia is generally not required — the needle is thin and most women experience only brief discomfort.
The thin needle (transabdominal) or flexible catheter (transcervical) is guided precisely to the placenta under continuous real-time ultrasound visualisation. The image on screen shows the instrument position throughout — it does not approach the baby.
A small amount of chorionic villi (placental tissue) is withdrawn by gentle aspiration. The sample is a few milligrams — enough for full genetic analysis. The placenta continues to function normally after the biopsy.
As soon as the needle or catheter is removed, Dr. Kunda checks the fetal heartbeat and the puncture site on ultrasound. You will rest at the clinic for 20–30 minutes before leaving. Anti-D injection is given to Rh-negative women before discharge.
The tissue sample is carefully labelled and dispatched to the genetics laboratory. Dr. Kunda gives you clear written instructions on the expected timeline, what to watch for at home, and exactly who to contact if you have concerns.
"After a high-risk screening result, the wait between 11 weeks and 15 weeks can feel unbearable for a family. CVS gives those families the same definitive chromosomal answers — in the first trimester, while there is still the most time to process, to decide, and to prepare. I have sat with many families before this procedure and after it. What they need most is not just a result — it is clarity given with honesty, and enough time to absorb it with care and without pressure. That is what we offer at Mayflower."
Related Services at Mayflower Clinic
If you have received a high-risk screening result or have been referred for CVS, Dr. Kunda Shahane will review your case personally and guide you through every step — with expertise, honesty, and compassion. You do not have to face this alone.
Mayflower Fetal Medicine Centre · Dhantoli, Nagpur 440012 · Monday–Saturday 10:00 AM – 6:00 PM
Mayflower Fetal Medicine & High-Risk Pregnancy Centre, Dhantoli, Nagpur, provides fetal ultrasound, prenatal diagnosis, fetal echocardiography, Doppler studies, genetic counseling and high-risk pregnancy care under Dr. Kunda Shahane.

Fetal Echocardiography: Detecting Heart Defects before Birth…

High-Risk Pregnancy: How Fetal Medicine Supports Moms…
Surdham Complex, Behind Silver Palace Building, 2nd Lane from Panchsheel Sq., Opp. Yashwant Stadium, Dhantoli Nagpur - 440012
07126692706
whatsapp 8087471244
